You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

~ Buy the VYZULTA (latanoprostene bunod) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VYZULTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VYZULTA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03931317 ↗ Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity Completed Bausch & Lomb Incorporated N/A 2018-12-03 The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
NCT03931317 ↗ Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity Completed University of California, San Diego N/A 2018-12-03 The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye.
NCT03949244 ↗ Nailfold Capillary Blood Flow With Latanoprost Bunod Completed Icahn School of Medicine at Mount Sinai Phase 4 2019-08-15 The purpose of this study is to look at the relationship of small blood vessels irregularities observed with an imaging system called video nailfold capillaroscopy in people with primary open-angle glaucoma. Nailfold capillaroscopy (NFC) is a video camera with a magnifying lens used for studying the movement of blood in small blood vessels. It is simple, safe and does not penetrate the skin. The skin fold that is at the tip of the finger is called the "nailfold". NFC has been used to assess blood vessel narrowing in patients with glaucoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VYZULTA

Condition Name

Condition Name for VYZULTA
Intervention Trials
Glaucoma, Open-Angle 1
OAG - Open-Angle Glaucoma 1
OHT - Ocular Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VYZULTA
Intervention Trials
Glaucoma, Open-Angle 2
Ocular Hypertension 1
Hypertension 1
Glaucoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VYZULTA

Trials by Country

Trials by Country for VYZULTA
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for VYZULTA
Location Trials
New York 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VYZULTA

Clinical Trial Phase

Clinical Trial Phase for VYZULTA
Clinical Trial Phase Trials
Phase 4 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VYZULTA
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VYZULTA

Sponsor Name

Sponsor Name for VYZULTA
Sponsor Trials
University of California, San Diego 1
Icahn School of Medicine at Mount Sinai 1
Bausch & Lomb Incorporated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VYZULTA
Sponsor Trials
Other 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.